scholarly journals Orbital Cellulitis in Children: Experience of the Pediatric Service at Mohammed v Military Hospital

2021 ◽  
pp. 6-9
Author(s):  
Jihane Elmahi ◽  
A. Radi ◽  
M. Kmari ◽  
A. Hassani ◽  
R. Abilkasseme ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Orbital Cellulitis ◽  
Military Hospital ◽  
Preseptal Cellulitis ◽  
Orbital Abscess ◽  
Pediatric Service ◽  
Micro Organisms ◽  
Positive Evolution ◽  
Multidisciplinary Patient Care

Background: Orbital cellulitis is a diagnostic and therapeutic emergency, jeopardizing the  vital and functional prognosis. This study aimed to analyze the epidemiological, therapeutic and evolutional aspects of orbital cellulitis cases treated at the pediatric service at Mohamed V military hospital. Patients and methods: retrospective study including all the children aged between 1 month and 15 years treated for orbital cellulitis at the pediatric service of the Mohamed V Hospital over a period of 3 years (1st January 2016-31st December 2019). Results: 24 cases of orbital cellulitis were gathered. Age varied between 1 month and 15 years with a median of age of 6. years. Feminine predominance (58%) was noted . The disease mainly involved the sinus (32%).Clinically, fever was present in 10 patients (41%),palpebral edema was universal, proptosis was noted in 5 cases(20.8%),chemosis and ptosis were noted in 4 cases(16.6%),bacteriological testing identified micro-organisms in 3 cases. An orbital CT scan was performed in all cases of our study, showing preseptal cellulitis in 14 cases (58.3%), orbital cellulitis in 3 cases(12.5%),and orbital abscess in 7 cases. The medical treatment consisted of ceftriaxone, metronidazole and aminoside or amoxicilline clavulanic acid, corticosteroid therapy prescribed in 5 cases. Surgical treatment was indicated in 3 patients. The outcome of All cases was favorable. Conclusion: The majority of our cases had a positive evolution highlighting the advantage of an early diagnosis, and adapted antibiotic and a multidisciplinary patient care making the need for surgery rarely necessary.

scholarly journals Management of Periorbital and Orbital Cellulitis at the Pediatric Emergency Department

2020 ◽  
Author(s):  
Widad Lahmini ◽  
mounir bourrous
Keyword(s):  
Soft Tissues ◽  
Pediatric Emergency ◽  
Orbital Cellulitis ◽  
University Hospital ◽  
Emergency Unit ◽  
Bacteriological Study ◽  
Subperiosteal Abscess ◽  
Preseptal Cellulitis ◽  
Orbital Abscess ◽  
Positive Evolution

Abstract Background : Orbital cellulitis is a diagnostic and therapeutic emergency, jeopardizing the vital and functional prognosis. This study aimed to analyze the epidemiological, therapeutic and evolutional aspects of orbital cellulitis cases treated at the pediatric emergency unit. Patients and methods: retrospective study including all the children aged between 1 month and 15 years treated for orbital cellulitis at the pediatric emergency unit of the Mohamed VI University Hospital of Marrakech over a period of 9 years (1st January 2010-31st December 2018). Results: 129 cases of orbital cellulitis were gathered. Age varied between 1 month and 15 years with a median of age of 4.3 years. Feminine predominance (54%) was noted (sex ratio of 0.84). Preseptal cellulitis had the lead with 101 cases (78.2%). It mainly breaks through sinuses (24%). Fever was present in 101 patients (78.2%). Palpebral edema was constant. Exophthalmia was noted in 18 patients (13.9%), chemosis in 29 cases (22.4%) while ptosis was found in one patient. Bacteriological study conducted in 12 cases was positive in 7 cases. An orbital CT scan was performed in all cases of our study, showing preseptal cellulitis in 101 patients (78.2%), orbital cellulitis in 11 cases (8.5%), subperiosteal abscess in 15 cases (11.6%) and orbital abscess in 2 cases (1.5%). The medical treatment consisted of ceftriaxone, metronidazole and aminoside or amoxicilline clavulanic acid. Surgical treatment was indicated in 8 patients : 3 cases of orbital abscess, 2 cases of periosteal abscess, and 3 cases of abscessed collection of the soft tissues. The evolution was beneficial in all our patients. Conclusion: The majority of our cases had a positive evolution highlighting the advantage of an early diagnosis, and adapted antibiotic and a multidisciplinary patient care making the need for surgery rarely necessary.

scholarly journals Pediatrics Orbital and Preseptal Cellulitis: A 2-year Experience

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Elham Shafighi Shahri ◽  
Seyed Hosein Soleimanzadeh Mousavi ◽  
Jamaladdin Osmani ◽  
Gholamreza Soleimani
Keyword(s):  
Retrospective Study ◽  
Clinical Features ◽  
Orbital Cellulitis ◽  
University Hospital ◽  
Preseptal Cellulitis ◽  
Timely Treatment ◽  
Edema Of The Eyelids

Objectives: To investigate the epidemiology, clinical features, and treatment of hospitalized pediatric cases of preseptal and orbital cellulitis in a central university hospital in Zahedan, Iran. Methods: Retrospective study of children/adolescents admitted to a central university hospital with orbital and preseptal cellulitis from 2016 to 2018. Results: Forty patients, including 29 cases of preseptal cellulitis and 11 cases of orbital cellulitis, were included in the study. The prevalence of orbital and preseptal cellulitis was approximately the same in both sexes. Mean age was 2.86 ± 0.56 years (ranges 12 days to 13 years) in patients with orbital cellulitis and 2.82 ± 0.67 years (range, 2 months to 8 years) in patients with preseptal cellulitis. The most common clinical and paraclinical findings were edema of the eyelids and increased ESR, respectively. Sinusitis is the most common underlying cause, which was present in 63.63% of cases of orbital cellulitis and 34.48% of cases of preseptal cellulitis. The most frequent antibiotics used in this study were ceftriaxone, cloxacillin, and vancomycin. Conclusions: The most common clinical and paraclinical findings were edema of the eyelids and increased ESR, respectively. Sinusitis is the most common underlying cause. Timely treatment of sinusitis may prevent orbital and preseptal cellulitis.

Differentiation of Orbital Cellulitis From Preseptal Cellulitis by Computed Tomography

PEDIATRICS ◽  
1978 ◽  
Vol 62 (6) ◽  
pp. 1000-1005
Author(s):  
Frederick Goldberg ◽  
Alfred S. Berne ◽  
Frank A. Oski
Keyword(s):  
Computed Tomography ◽  
Ct Scanning ◽  
Orbital Cellulitis ◽  
Ct Scans ◽  
Preseptal Cellulitis ◽  
Orbital Abscess ◽  
Eyelid Edema ◽  
Eye Examination ◽  
Loss Of Visual Acuity ◽  
Orbital Disease

Computed tomography (CT) was used in the management of four patients with periorbital inflammation. These patients were selected for CT scanning because of the difficulty, on clinical examination alone, in determining the degree of orbital disease. The CT scans confirmed the presence and defined the location of an orbital abscess in three patients and eliminated the presence of an abscess in the fourth. On the basis of this experience, CT scanning is recommended in the evaluation of children with periorbital inflammation in whom proptosis, ophthalmoplegia, or loss of visual acuity develops, or in whom severe eyelid edema prevents adequate eye examination.

scholarly journals ENT Disorders Presenting with Ophthalmological Manifestations:An Overview

2020 ◽  
Vol 9 (1) ◽  
pp. OT12-OT16
Author(s):  
Sathyalakshmi M H ◽  
Girish F Hongal
Keyword(s):  
Retrospective Study ◽  
Sinus Thrombosis ◽  
Orbital Cellulitis ◽  
High Morbidity ◽  
Cavernous Sinus Thrombosis ◽  
Orbital Abscess ◽  
Late Treatment ◽  
Spread Of Infection ◽  
Optic Nerve Compression ◽  
Ent Disorders

Background: It is important to diagnose the condition early and manage aggressively. It is often difficult to cure orbital cellulitis due to late treatment and may cause blindness if left untreated because of optic nerve compression. Both orbital abscess and cavernous sinus thrombosis may lead to intracranial spread of infection, such as meningitis or cerebral abscess with high morbidity and possible mortality.Subjects and Methods:A total number of 124 cases of ophthalmological manifestation caused by various ENT diseases, mostly paranasaltumourextensions; nasopharyngeal tumour and furunculosis of nose were analyzed in a retrospective study in relation to their age, sex, clinical,radiological and histopathologicalprofile.Results: Direct nasal endoscopy(DNE), Fibre optic Flexible nasopharyngoscopy was Useful. HRCT scan was considered as the most dependable investigating tool. Different modalities of medical and surgical treatment have been adopted according to location and nature of diseases.Conclusion: Aclose co-operationand team effort required between otorhinolaryngologist and ophthalmologist to overcome this kind of challenges.

scholarly journals The Dose of Somatostatin Analogues during Pre-Surgical Treatment Is a Key Factor to Achieve Surgical Remission in Acromegaly

Endocrines ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 241-250
Author(s):  
Marta Araujo-Castro ◽  
Eider Pascual-Corrales ◽  
Héctor Pian ◽  
Ignacio Ruz-Caracuel ◽  
Alberto Acitores Cancela ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Surgical Outcomes ◽  
Pituitary Adenomas ◽  
Somatostatin Analogues ◽  
Beneficial Effects ◽  
Key Factor ◽  
Long Acting ◽  
First Time ◽  
Endocrine Complications

Purpose: to determine whether pre-surgical treatment using long-acting somatostatin analogues (SSAs) may improve surgical outcomes in acromegaly. Methods: retrospective study of 48 patients with acromegaly operated by endoscopic transsphenoidal approach and for first time. Surgical remission was evaluated based on the 2010 criteria. Results: most patients, 83.3% (n = 40), harbored macroadenomas and 31.3% (n = 15) invasive pituitary adenomas. In this case, 14 patients were treated with lanreotide LAR and 6 with octreotide LAR, median monthly doses of 97.5 [range 60–120] and 20 [range 20–30] mg, respectively, for at least 3 months preoperatively. Presurgical variables were comparable between pre-treated and untreated patients (p > 0.05). Surgical remission was more frequent in those pre-treated with monthly doses ≥90 mg of lanreotide or ≥30 mg of octreotide than in untreated or pre-treated with lower doses (OR = 4.64, p = 0.025). However, no differences were found between pre-treated and untreated patients when lower doses were included or between those treated for longer than 6 months compared to those untreated or pre-treated for shorter than 6 months. Similarly, no differences were found either in terms of surgical or endocrine complications (OR = 0.65, p = 0.570), independently of the doses and the duration of SSA treatment (p > 0.05). Conclusions: the dose of SSAs is a key factor during pre-surgical treatment, since the beneficial effects in surgical remission were observed with monthly doses equal or higher than 90 mg of lanreotide and 30 mg of octreotide, but not with lower doses.

Sign in / Sign up

Export Citation Format

Share Document